Skip to main content

Our Research – University of Reading

Show access keys
  • Internationally excellent research

    At the Reading School of Pharmacy

Our Research

Research at the Reading School of Pharmacy attracts support and funding from the government (through the Research Councils, Innovate UK and the Global Challenges Research Fund), major charities and industry. In the 2014 Research Excellence Framework 85% of our research was recognised as being internationally excellent, with the Reading School of Pharmacy ranked 20th out of 94 submissions by research outputs.

A key part of our research is our graduate training program, with PhD students in the School funded by charities, such as the British Heart Foundation, Alzheimer's Association and Parkinson's UK, and industry partnerships including Medpharm, Ludger, ThermoFisher Scientific, Dextra Laboratories, BC Platforms and GW Pharmaceuticals.

Our main areas of research

Research within the Reading School of Pharmacy brings together experts from across the health sciences with the goal of improving how we use existing medicines and developing the new drugs of tomorrow. Particular areas of research excellence include:

  • Developing and characterising new molecules for drug discovery
  • Cutting-edge materials for therapeutic applications
  • Identifying new targets in cardiovascular disease, neurodegeneration and cancer
  • Safer medicines and better practitioners
  • Novel technologies for rapid diagnostics

research institutions at the University of Reading

The Reading School of Pharmacy conducts ground-breaking research alongside two research centres at the University.

These are the Centre for Integrative Neuroscience and Neurodynamics (CINN) and the Institute for Cardiovascular and Metabolic Research (ICMR).

Pharmacy research and phd projects

To gain more of an insight into the research currently going on at the Reading School of Pharmacy, you can see our PhD projects where all studies are listed.

Learn about some of our academics

"Developing more relevant human in vitro models of disease can help us to better investigate the underlying causes. As such, they may also help to identify new therapeutic targets and test drug candidates."

Dr Angela Bithell

Lecturer in Stem Cell Biology

"What I'm really excited about at the moment is that we've developed a prototype product for heart attack testing, but the same technology could be used for many different applications. We've gone from having an idea, showing the idea works in the lab, building a prototype of the final product, and the next stage is to test that prototype with human samples, that's why we're working with the local hospital, the Royal Berkshire Hospital, to see whether we can test our device and see how useful it could be in an NHS A&E Department."

Dr Al Edwards

Associate Professor in Biomedical Technology

We use Javascript to improve your experience on, but it looks like yours is turned off. Everything will still work, but it is even more beautiful with Javascript in action. Find out more about why and how to turn it back on here.
We also use cookies to improve your time on the site, for more information please see our cookie policy.

Back to top